Cargando…
Bone-Marrow-Derived Mesenchymal Stromal Cells (MSC) from Diabetic and Nondiabetic Rats Have Similar Therapeutic Potentials
BACKGROUND: Diabetes mellitus is a severe chronic disease leading to systemic complications, including cardiovascular dysfunction. Previous cell therapy studies have obtained promising results with the use bone marrow mesenchymal stromal cells derived from healthy animals (MSCc) in diabetes animal m...
Autores principales: | José, Vitória Santório de São, Monnerat, Gustavo, Guerra, Barbara, Paredes, Bruno Dias, Kasai-Brunswick, Tais Hanae, de Carvalho, Antonio Carlos Campos, Medei, Emiliano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Sociedade Brasileira de Cardiologia - SBC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5783439/ https://www.ncbi.nlm.nih.gov/pubmed/29364350 http://dx.doi.org/10.5935/abc.20170176 |
Ejemplares similares
-
Intrinsic Angiogenic Potential and Migration Capacity of Human Mesenchymal Stromal Cells Derived from Menstrual Blood and Bone Marrow
por: Santos, Rosana de Almeida, et al.
Publicado: (2020) -
Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists
por: Evaristo-Mendonça, Fabiana, et al.
Publicado: (2019) -
Stem cell therapies in cardiac diseases: Current status and future possibilities
por: Kasai-Brunswick, Tais Hanae, et al.
Publicado: (2021) -
Erratum to “Preconditioning of Rat Bone Marrow-Derived Mesenchymal Stromal Cells with Toll-Like Receptor Agonists”
por: Evaristo-Mendonça, Fabiana, et al.
Publicado: (2020) -
Proteomics in the World of Induced Pluripotent Stem Cells
por: Lindoso, Rafael Soares, et al.
Publicado: (2019)